Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

What if the secret to staying young wasn't another costly cream or trendy supplement, but tamping down a messy kind of cell ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that ...

Research from the University of Cincinnati reveals how the MYC oncogene alters PRPS enzymes, impacting redox homeostasis and ...

Pipetting brain organoids at Fides Zenk's laboratory - 2025 EPFL/Zenk Lab Organoids are a promising breakthrough that scientists have been exploring ...

Our murine tumor organoid system faithfully models lung cancer cell states at both the gene expression level and the chromatin accessibility level, providing a means to identify and test key ...

Reproducibility is a buzzword in the world of scientific research. Frequently, it is followed by the jarring, but often apt, term “crisis,” to describe the dangerous implications that emerge when one ...

Cancer remains one of the most complex diseases ... Published (DOI: 10.26599/CO.2024.9410009) in Cell Organoid on December 25, 2024. While comparing mechanical dissociation and enzymatic digestion ...

And while it can take months to grow enough cancer cells in the lab on which to test treatments, an organoid can be generated in 2–3 weeks while the individuals recover from surgery and before ...